Takehiro Otoshi

722 citations

30 papers · 489 indexed · h-index 11

Impact in

Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory Support and Mechanisms
- Occupational and environmental lung diseases
Oncology
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in ⓘ

Pulmonary and Respiratory Medicine 20
- Lung Cancer Treatments and Mutations 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Respiratory Support and Mechanisms 4
- Lung Cancer Diagnosis and Treatment 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Pleural and Pulmonary Diseases 2
Oncology 9
- Lung Cancer Research Studies 4

Co-authors: Yoshihiro Nishimura (12 shared papers)Tatsuya Nagano (12 shared papers)Keisuke Tomii (11 shared papers)Kojiro Otsuka (11 shared papers)Atsushi Nakagawa (11 shared papers)Kazuma Nagata (10 shared papers)Daichi Fujimoto (10 shared papers)Motoko Tachihara (8 shared papers)
Journals: Medicine (3 papers)Anticancer Research (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)Lung (1 paper)
Partner nations: Japan United States Israel

In The Last Decade

Takehiro Otoshi

29 papers receiving 484 citations

Peers

Countries citing papers authored by Takehiro Otoshi

Since Specialization

Citations

This map shows the geographic impact of Takehiro Otoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Otoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Otoshi more than expected).

Fields of papers citing papers by Takehiro Otoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Otoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Otoshi. The network helps show where Takehiro Otoshi may publish in the future.

Co-authors

The 25 scholars most cited alongside Takehiro Otoshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takehiro Otoshi Line = papers co-authored together Takehiro Otoshi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer Anticancer Research ·Masahiro Katsurada, Tatsuya Nagano, Motoko Tachihara, Tatsunori Kiriu, Koichi Furukawa, K Koyama, Takehiro Otoshi, Reina Sekiya, Daisuke Hazama, Daisuke Tamura, Kyosuke Nakata, Naoko Katsurada, Masatsugu Yamamoto, Kazuyuki Kobayashi, Yoshihiro Nishimura	2019	74
2	Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical Ventilation Respiratory Care ·Kazuma Nagata, Takeshi Morimoto, Daichi Fujimoto, Takehiro Otoshi, Atsushi Nakagawa, Kojiro Otsuka, Ryutaro Seo, Takahiro Atsumi, Keisuke Tomii	2015	47
3	Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis Clinical & Experimental Metastasis ·Daichi Fujimoto, Hiroyuki Ueda, Ryoko Shimizu, Ryoji Kato, Takehiro Otoshi, Takahisa Kawamura, Koji Tamai, Yumi Shibata, Takeshi Matsumoto, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii	2014	47
4	Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation Journal of Thoracic Oncology ·Kosuke Tanaka, Akito Hata, Reiko Kaji, Shiro Fujita, Takehiro Otoshi, Daichi Fujimoto, Takahisa Kawamura, Koji Tamai, Jumpei Takeshita, Takeshi Matsumoto, Kazuya Monden, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Ryo Tachikawa, Kojiro Otsuka, Keisuke Tomii, Nobuyuki Katakami	2013	41
5	The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease Cancer Chemotherapy and Pharmacology ·Ryoko Shimizu, Daichi Fujimoto, Ryoji Kato, Takehiro Otoshi, Takahisa Kawamura, Koji Tamai, Takeshi Matsumoto, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii	2014	39
6	Possible Biomarkers for Cancer Immunotherapy Cancers ·Takehiro Otoshi, Tatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura	2019	37
7	Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma Lung Cancer ·Daichi Fujimoto, Keisuke Tomii, Takehiro Otoshi, Takahisa Kawamura, Koji Tamai, Junpei Takeshita, Kosuke Tanaka, Takeshi Matsumoto, Kazuya Monden, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Akito Hata, Ryo Tachikawa, Kojiro Otsuka, Hiroshi Hamakawa, Nobuyuki Katakami, Yutaka Takahashi, Yukihiro Imai	2013	29
8	<p>Novel cancer therapy targeting microbiome</p> OncoTargets and Therapy ·Tatsuya Nagano, Takehiro Otoshi, Daisuke Hazama, Tatsunori Kiriu, Kanoko Umezawa, Naoko Katsurada, Yoshihiro Nishimura	2019	26
9	A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensor Scientific Reports ·Takehiro Otoshi, Tatsuya Nagano, Shintaro Izumi, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Kazuyuki Kobayashi, Yoshihiro Nishimura	2021	20
10	Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center PLoS ONE ·Takehiro Otoshi, Yuki Kataoka, Shunkichi Ikegaki, Emiko Saito, Hirotaka Matsumoto, Sawako Kaku, Masatoshi Shimada, Masataka Hirabayashi	2017	17
11	Prognostic Value of Bronchoalveolar Lavage in Patients with Non-HIV Pneumocystis Pneumonia Internal Medicine ·Koji Tamai, Ryo Tachikawa, Keisuke Tomii, Kazuma Nagata, Kojiro Otsuka, Atsushi Nakagawa, Kyoko Otsuka, Takeshi Matsumoto, Kazuya Monden, Jumpei Takeshita, Kosuke Tanaka, Takahisa Kawamura, Takehiro Otoshi, Daichi Fujimoto	2014	14
12	Analysis of advanced lung cancer patients diagnosed following emergency admission European Respiratory Journal ·Daichi Fujimoto, Ryoko Shimizu, Takeshi Morimoto, Ryoji Kato, Yuki Sato, Mariko Kogo, Jiro Ito, Shunsuke Teraoka, Takehiro Otoshi, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii	2014	10
13	Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lung eLife ·Akihiro Miura, Hemanta Sarmah, Junichi Tanaka, Youngmin Hwang, Anri Sawada, Yuko Shimamura, Takehiro Otoshi, Yuri Kondo, Yinshan Fang, Dai Shimizu, Zurab Ninish, Jake Le Suer, Nicole Dubois, Jennifer Davis, Shinichi Toyooka, Jun Wu, Jianwen Que, Finn Hawkins, Chyuan‐Sheng Lin, Munemasa Mori	2023	10
14	The Gut Microbiome as a Biomarker of Cancer Progression Among Female Never-smokers With Lung Adenocarcinoma Anticancer Research ·Takehiro Otoshi, Tatsuya Nagano, Jonguk Park, Koji Hosomi, Tomoya Yamashita, Motoko Tachihara, Tokiko Tabata, Reina Sekiya, Yugo Tanaka, Kazuyuki Kobayashi, Kenji Mizuguchi, Tomoo Itoh, Yoshimasa Maniwa, Jun Kunisawa, Yoshihiro Nishimura	2022	9
15	Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolam Experimental and Therapeutic Medicine ·Takeshi Matsumoto, Kojiro Otsuka, Ryoji Kato, Ryoko Shimizu, Takehiro Otoshi, Daichi Fujimoto, Takahisa Kawamura, Koji Tamai, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Keisuke Tomii	2015	9
16	A Cross-sectional Survey of the Clinical Manifestations and Underlying Illness of Cough In Vivo ·Takehiro Otoshi, Tatsuya Nagano, Yasuhiro Funada, Kazuhiro Takenaka, Hiroyuki Nakata, Hisashi Ohnishi, Teruaki Nishiuma, Takeo Nakajima, Toshiaki Kageshita, Takaaki Tsuchiya, Masatsugu Yamamoto, Kazuyuki Kobayashi, Yoshihiro Nishimura	2019	8
17	Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease. PubMed ·Daichi Fujimoto, Ryoko Shimizu, Ryoji Kato, Yuki Sato, Mariko Kogo, Jiro Ito, Shunsuke Teraoka, Takehiro Otoshi, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii	2015	8
18	Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma In Vivo ·Takehiro Otoshi, Yuki Kataoka, Sawako Kaku, Reika Iki, Masataka Hirabayashi	2018	7
19	Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective study PLoS ONE ·Naoko Katsurada, Motoko Tachihara, Naoe Jimbo, Masatsugu Yamamoto, Junya Yoshioka, Chihiro Mimura, Hiroki Satoh, Koichi Furukawa, Takehiro Otoshi, Tatsunori Kiriu, Yuichiro Yasuda, Tomonori Tanaka, Tatsuya Nagano, Yoshihiro Nishimura	2021	6
20	Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study Lung ·Takehiro Otoshi, Yuki Kataoka, Atsushi Nakagawa, Kojiro Otsuka, Keisuke Tomii	2016	6

About Takehiro Otoshi

Takehiro Otoshi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Molecular Biology and Anesthesiology and Pain Medicine, having authored 30 papers that have together received 489 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Respiratory Support and Mechanisms (4 papers), Lung Cancer Research Studies (4 papers), Asthma and respiratory diseases (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Pleural and Pulmonary Diseases (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (332 citations), Oncology (213 citations), Anesthesiology and Pain Medicine (33 citations), Critical Care and Intensive Care Medicine (22 citations) and Otorhinolaryngology (10 citations). Takehiro Otoshi has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Yoshihiro Nishimura, Tatsuya Nagano, Keisuke Tomii, Kojiro Otsuka, Atsushi Nakagawa, Kazuma Nagata, Daichi Fujimoto, Motoko Tachihara, Kyoko Otsuka and Naoko Katsurada. Their work appears in journals such as Medicine, Anticancer Research, PLoS ONE, Scientific Reports and Lung.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact